Position in BMRN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,567,505
-$12,908,745 QoQ
Shares Held
97,300
-68.7% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#147
of 561 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. BMRN ranks #97 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in BMRN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,567,505 | 97,300 | Shares | Other | 2026-08-13 | |
| 2025-12-31 | $18,476,250 | 310,891 | Shares | Other | 2026-02-13 | |
| 2025-06-30 | $4,609,343 | 83,852 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $1,013,482 | 14,337 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $44,735,443 | 680,594 | Shares | Other | 2025-02-13 | |
| 2024-06-30 | $3,518,619 | 42,738 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $6,905,886 | 79,069 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $41,590,092 | 431,343 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $18,376,145 | 207,687 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $18,664,110 | 215,322 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $1,459,864 | 15,013 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $62,122,149 | 600,272 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $39,075,494 | 460,959 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $48,778,773 | 588,618 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $28,232,478 | 366,180 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $55,610,493 | 629,434 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $25,968,280 | 335,985 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,416,951 | 40,951 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $5,646,885 | 64,396 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $22,483,542 | 295,525 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $9,899,391 | 80,261 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $950,287 | 11,246 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||